Nelson, Van Denburg & Campbell Wealth Management »

Heron Therapeutics shares owned by Nelson, Van Denburg & Campbell Wealth Management

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Nelson, Van Denburg & Campbell Wealth Management from 13F filings

Historical chart of Nelson, Van Denburg & Campbell Wealth Management investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Nelson, Van Denburg & Campbell Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Nelson, Van Denburg & Campbell Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6k 1.3k 1.99
2024-06-30 $4.6k 1.3k 3.50
2024-03-31 $3.7k 1.3k 2.77
2023-12-31 $2.2k 1.3k 1.70

More positions owned by Nelson, Van Denburg & Campbell Wealth Management

Vanguard Growth Etf Etf (VUG)
Ishares Core Dividend Growth Etf Etf (DGRO)
Vanguard Index Fds Mid-cap Value Index Viper Shs Etf Etf (VOE)
Vanguard Mid Cap Growth Etf Etf (VOT)
Ishares S&p 500 Index Etf (IVV)
Jpmorgan Active Value Etf Etf (JAVA)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Jpmorgan Active Growth Etf Etf (JGRO)
Ishares Morningstar Mid-cap Growth Etf Etf (IMCG)
Apple Stock (AAPL)
Invesco Bulletshares 2029 Corporate Bond Etf Etf (BSCT)
Invesco Bulletshares 2027 Corporate Bond Etf Etf (BSCR)
Invesco Bulletshares 2025 Corporate Bond Etf Etf (BSCP)
Vanguard S&p 500 Etf Etf (VOO)
Spdr Ser Tr Dj Wilshire Small Cap Value Etf Etf (SLYV)

View all positions for Nelson, Van Denburg & Campbell Wealth Management

Top funds holding Heron Therapeutics

Rubric Capital Management
Vanguard Group
BlackRock
BlackRock
Tejara Capital
State Street Corporation
D. E. Shaw & Co
Palisade Capital Management
Geode Capital Management
JW Asset Management
Clearline Capital
Renaissance Technologies
Orchard Capital Managment
Congress Park Capital
Tang Capital Management

View all funds holding Heron Therapeutics